Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

ProPhase Labs Q3 EPS $(0.30) Misses $(0.20) Estimate, Sales $8.37M Miss $13.06M Estimate

Author: Benzinga Newsdesk | November 09, 2023 09:01am

ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 600 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $8.37 million which missed the analyst consensus estimate of $13.06 million by 35.95 percent. This is a 65.43 percent decrease over sales of $24.20 million the same period last year.

Posted In: PRPH